Long intergenic non-protein coding RNA 1754 (LINC01754)

Long intergenic non-protein coding RNA 1754 (LINC01754) is a member of the long non-coding RNA (lncRNA) family, specifically categorized as a long intergenic non-protein coding RNA (LINC)[13][16][3]. It does not encode a protein but produces an RNA molecule over 200 nucleotides in length. LINC01754 is located on chromosome 20q13.12, on the reverse strand[13][5][11]. Its sequence and genomic properties are cataloged in human genome databases, including HGNC, Ensembl, and LNCipedia[11][5][13]. While the specific biological function, disease roles, and clinical significance of LINC01754 are not well established, lincRNAs in general are known to regulate gene expression via various mechanisms such as chromatin modulation, serving as scaffolds for ribonucleoprotein complexes, and impacting cell differentiation and proliferation[7][16][3]. Some other lincRNAs have demonstrated roles in cancer progression, acting as oncogenes or tumor suppressors, but no direct evidence links LINC01754 to a specific disease or therapeutic context at present[7][12]. There are currently no known drugs, mechanisms of action, biomarker utilities, or reported safety concerns associated with LINC01754. Databases do not list LINC01754 as a recognized therapeutic target, and no clinically actionable features are described[13][15][3]. In summary, LINC01754 is a non-coding RNA gene with a formally approved nomenclature but without characterized functional or pathological roles, serving primarily as a genomic annotation rather than as a validated drug target[13][3][1].

Other names

LINC01754long intergenic non-protein coding RNA 1754